Frank Hsu
Director/Board Member at Karin Grunebaum Cancer Research Foundation
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joel Peterson | M | 77 |
Stanford University
| 32 years |
| Linda M. Dairiki Shortliffe | M | 75 |
Stanford University
| 31 years |
| Byoung Yoon Kim | M | - |
Stanford University
| 34 years |
| Mari Baker | F | 59 |
Stanford University
| 28 years |
| Paulraj Arogyaswami | M | 79 |
Stanford University
| 31 years |
| Gunnar E. Carlsson | M | - |
Stanford University
| 33 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Kiener | M | 72 |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | 4 years |
| James Rickey | M | 45 | 6 years | |
| Henri A. Termeer | M | 78 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 28 years |
| Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| William Sibold | M | 57 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Stephen van Horne | M | - |
Stanford University
| 2 years |
| Gary Zweiger | M | - |
Stanford University
| 11 years |
| Kurt Zimmerman | M | - |
Stanford University
| 5 years |
| Puneet Agarwal | M | - |
Stanford University
| 5 years |
| Derek R. Armfield | M | - |
Stanford University
| 5 years |
| Sameer Dholakia | M | 50 |
Stanford University
| 4 years |
| Erik Falk | M | 54 |
Stanford University
| 4 years |
| Boyd Fowler | M | - |
Stanford University
| 5 years |
| Chris Jones | M | 56 |
Stanford University
| 5 years |
| Benjamin Chelf | M | - |
Stanford University
| 6 years |
| Teresa Kong | F | - |
Stanford University
| 5 years |
| David Tony Lillios | M | - |
Stanford University
| 5 years |
| Roger W. Louis | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Jeffrey Bede | M | - |
Stanford University
| 4 years |
| Tobin C. Island | M | 57 |
Stanford University
| 5 years |
| Susan Kelley | M | 69 | 3 years | |
| Alex Kunczynski | M | - |
Stanford University
| 5 years |
| Matthew E. Spiegelman | M | - |
Stanford University
| 5 years |
| Christopher Whitmore | M | - | - | |
| Van Ton-Quinlivan | M | - |
Stanford University
| 2 years |
| Jené Elzie | F | 49 |
Stanford University
| 5 years |
| Márcio Gomes Pinto Garcia | M | 64 |
Stanford University
| 3 years |
| Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
| Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Jennifer Wu | F | - |
Stanford University
| 9 years |
| Michael Halpin | M | 62 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
| Y. Dan Rubinstein | M | - |
Stanford University
| 6 years |
| Michael Wyzga | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 years |
| Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
| Cipora Herman | F | 50 |
Stanford University
| 5 years |
| Chih-Kong Ken Yang | M | - |
Stanford University
| 5 years |
| Mauria Finley | F | 50 |
Stanford University
| 5 years |
| Ashley Johnson | F | 52 |
Stanford University
| 6 years |
| Mark V. Matthews | M | - |
Stanford University
| 6 years |
| Lawrence S. Malkin | M | - |
Stanford University
| 4 years |
| Larry Alder | M | - |
Stanford University
| 6 years |
| Eleanor de Groot | M | 55 |
Stanford University
| 5 years |
| Robert Neivert | M | - |
Stanford University
| 3 years |
| Sasa Zorovic | M | - |
Stanford University
| 6 years |
| Henry E. Blair | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 years |
| Kevin Efrusy | M | 51 |
Stanford University
| 5 years |
| Selena Chaisson | M | - |
Stanford University
| 5 years |
| William Staib | M | - |
Stanford University
| 4 years |
| Kenneth McBride | M | 56 |
Stanford University
| 6 years |
| William Ringo | M | 78 | 5 years | |
| Jason Terrance Holzer | M | 52 |
Stanford University
| 4 years |
| Brian Atwood | M | 71 | 8 years | |
| Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Eric Selmon | M | - |
Stanford University
| 5 years |
| Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
| Richard F. Syron | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Lewis Coleman | M | 82 | 4 years | |
| Patrick Loulou | M | 55 |
Stanford University
| 4 years |
| Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| David ibnAle | M | 52 |
Stanford University
| 5 years |
| Franklin Berger | M | 74 | 5 years | |
| Ryan A. Harris | M | - |
Stanford University
| 6 years |
| Ahmed Farooq | M | - |
Stanford University
| 6 years |
| Jeff Stevens | M | - |
Stanford University
| 8 years |
| Anand Rajaraman | M | - |
Stanford University
| 3 years |
| Alexander Mihai Popovici | M | - |
Stanford University
| 5 years |
| Jessica Baron | F | 48 |
Stanford University
| 4 years |
| David Lam | M | - |
Stanford University
| 5 years |
| Robert Kalman | M | - |
Stanford University
| 6 years |
| Louis J. Arcudi | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 years |
| Tom Perkins | M | - |
Stanford University
| 3 years |
| Ravi Belani | M | - |
Stanford University
| 4 years |
| Mark Heinrich | M | - |
Stanford University
| 5 years |
| Thomas D. Willis | M | - |
Stanford University
| 3 years |
| Michael O'Connor | M | - |
Stanford University
| 5 years |
| Vincent K. Jones | M | - |
Stanford University
| 5 years |
| Kevin Stein | M | 58 |
Stanford University
| 5 years |
| Steve Herrod | M | - |
Stanford University
| 6 years |
| Thomas Stockham | M | 59 |
Stanford University
| 2 years |
| Ajay Agarwal | M | - |
Stanford University
| 4 years |
| Chris B. Hollenbeck | M | 54 |
Stanford University
| 5 years |
| Ryan Drant | M | 53 |
Stanford University
| 6 years |
| Daniel Scott Lyons | M | - |
Stanford University
| 6 years |
| Adam J. Grove | M | - |
Stanford University
| 3 years |
| Armand Wahyudi Hartono | M | 49 |
Stanford University
| 1 years |
| Andrew Buay | M | - |
Stanford University
| 1 years |
| Sarah H. Fandell | F | - |
Stanford University
| 4 years |
| Steven C. Voorhis | M | - |
Stanford University
| 4 years |
| Paul Asel | M | - |
Stanford University
| 2 years |
| Karen D. Cheng | M | - |
Stanford University
| 4 years |
| Pulakesh Mukherjee | M | - |
Stanford University
| 5 years |
| Mark Gudiksen | M | - |
Stanford University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Frank Hsu
- Personal Network
